Inventor
TARTAGLIA JAMES
US33 patents
⚠️ This page may combine multiple inventors who share the name “TARTAGLIA JAMES”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
VIROGENETICS CORP
17 patentsUS6265189B1Jul 24, 2001
Pox virus containing DNA encoding a cytokine and/or a tumor associated antigen
VIROGENETICS CORP155 citations99
US5833975ANov 10, 1998
Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence
VIROGENETICS CORP229 citations99
US6537594B1Mar 25, 2003
Vaccina virus comprising cytokine and/or tumor associated antigen genes
VIROGENETICS CORP77 citations98
US5990091ANov 23, 1999
Vectors having enhanced expression, and methods of making and uses thereof
VIROGENETICS CORP155 citations98
US5762938AJun 9, 1998
Modified recombinant vaccinia virus and expression vectors thereof
VIROGENETICS CORP180 citations98
US5756103AMay 26, 1998
Alvac canarypox virus recombinants comprising heterlogous inserts
VIROGENETICS CORP168 citations98
US6130066AOct 10, 2000
Vectors having enhanced expression and methods of making and uses thereof
VIROGENETICS CORP95 citations97
US5494807AFeb 27, 1996
NYVAC vaccinia virus recombinants comprising heterologous inserts
VIROGENETICS CORP377 citations97
US6004777ADec 21, 1999
Vectors having enhanced expression, and methods of making and uses thereof
VIROGENETICS CORP155 citations96
US5863542AJan 26, 1999
Recombinant attenuated ALVAC canaryopox virus containing heterologous HIV or SIV inserts
VIROGENETICS CORP44 citations96
US5766599AJun 16, 1998
Trova fowl pox virus recombinants comprising heterologous inserts
VIROGENETICS CORP90 citations96
US6596279B1Jul 22, 2003
Immunodeficiency recombinant poxvirus
VIROGENETICS CORP68 citations95
US5378457AJan 3, 1995
Interferon sensitive recombinant poxvirus vaccine
VIROGENETICS CORP43 citations93
US5756102AMay 26, 1998
Poxvirus-canine distemper virus (CDV) recombinants and compositions and methods employing the recombinants
VIROGENETICS CORP27 citations92
US5766598AJun 16, 1998
Recombinant attenuated ALVAC canarypoxvirus expression vectors containing heterologous DNA segments encoding lentiviral gene products
VIROGENETICS CORP47 citations89
US5759553AJun 2, 1998
Marek's disease virus recombinant poxvirus vaccine
VIROGENETICS CORP11 citations74
US5759552AJun 2, 1998
Marek's disease virus recombinant poxvirus vaccine
VIROGENETICS CORP7 citations74
AVENTIS PASTEUR
2 patentsCONNAUGHT TECHNOLOGY CORP
2 patentsSANOFI PASTEUR LTD
2 patentsUS HEALTH
2 patentsUS7094408B2Aug 22, 2006
Immunogenicity using a combination of DNA and vaccinia virus vector vaccines
US HEALTH12 citations80
US7771729B2Aug 10, 2010
Methods of potentiating HIV-1-specific CD8+ immune responses involving the concomitant administration of DNA and ALVAC expression vectors
US HEALTH2 citations59
ARIZONA BOARD OF REGENTS A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZON
2 patentsUS10370679B2Aug 6, 2019
Modified immunization vectors
ARIZONA BOARD OF REGENTS A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZON2 citations69
US12331307B2Jun 17, 2025
Modified immunization vectors
ARIZONA BOARD OF REGENTS A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZON0 citations59